Praxis Precision Medicine Analysts Raise Their Forecasts After Q4 Results

Praxis Precision Medicines, Inc. (NASDAQ:PRAX) reported a wider-than-expected loss for the fourth quarter on Thursday.The company posted quarterly losses of $3.50 per share which missed the analyst consensus estimate of losses of $3.08 per share.Praxis Precision Medicine shares fell 0.1% to trade at $303.00 on Friday.These analysts made changes to their price targets on Praxis Precision Medicine following earnings announcement.Wedbush analyst Laura Chico maintained Praxis Precision Medicine with an Underper ...